UBC’s recent global vaccine and infectious disease experience includes 42 projects encompassing clinical trials, observational studies, registries and safety surveillance.
Most notably, we quickly accelerated a study to collect information about the potential effects of a vaccine on developing fetuses during the H1N1 pandemic.
Our experts have authored and supported countless submissions to regulatory authorities on safety, efficacy and value, and remain current on the latest global regulatory trends and changes.
Read our experience summary
to learn more about our vaccine and infectious disease experience and contact us to discuss how we can support your business continuity during this critical time.